- US12433865utility2025Compositions Comprising Pgi2-receptor Agonists and Processes for the Preparation Thereof0 cites
- US12377067utility2025Methods of Treating PAH with Combinations of Ralinepag and Other Agents0 cites
- US12377071utility2025Methods of Treating Conditions Related to the S1P 1 Receptor0 cites
- US12239627utility2025Method of Treating Conditions Related to the PGI2 Receptor0 cites
- US12201633utility2025Compounds and Methods for Treatment of Visceral Pain0 cites
- USRE050267reissue2025Modulators of the Prostacyclin (PGI2) Receptor Useful for the Treatment of Disorders Related Thereto0 cites
- US12156866utility2024Methods of Treating Conditions Related to the S1P 1 Receptor0 cites
- US12115157utility20243-phenoxyazetidin-1-yl-heteroaryl Pyrrolidine Derivatives and the Use Thereof as Medicament0 cites
- US12109219utility2024Cannabinoid Receptor Modulators0 cites
- US12097182utility2024Compounds and Methods for Treatment of Inflammatory Bowel Disease with Extra-intestinal Manifestations0 cites
- US11896578utility2024Methods of Treating Conditions Related to the S1P 1 Receptor0 cites
- US11826337utility2023Method of Treating Conditions Related to the PGI2 Receptor0 cites
- US11826471utility2023Compositions Comprising Pgi2-receptor Agonists and Processes for the Preparation Thereof0 cites
- US11780827utility2023Substituted 3-phenoxyazetidin-1-yl-pyrazines0 cites
- US11771695utility2023Cannabinoid Receptor Modulators0 cites
- US11746091utility2023Cannabinoid Receptor Modulators0 cites
Page 1 of 2Next →